NEL Covid Medicines Delivery Unit for Non hospitalised patients

The NHS North East London Integrated Care Board has awarded a contract titled "NEL Covid Medicines Delivery Unit for Non-hospitalised patients" under the Health Care Services Provider Selection Regime (PSR) Regulations 2023. The awarded contract is for the delivery of health services, specifically tailored to providing COVID-19 medicine delivery for non-hospitalised patients. This tender falls under the service industry category and is located in London.

The contract was formally awarded on 3rd April 2025, following an intention to award notice published on 21st March 2025. The services are intended to be provided from 1st April 2025 to 30th September 2025, with an option for extension until 31st March 2026. The contract's approximate value for 12 months is £208,712.

This tender presents significant opportunities for businesses specialising in healthcare services, particularly those adept at managing COVID-19 related treatments outside hospital settings. The procurement method applied was a direct award process without prior publication of a call for competition, favouring providers who can assure quality, innovation, value for money, integration, collaboration, service sustainability, access improvement, health inequality reduction, choice facilitation, and social value. Companies with established performance in these areas, or those looking to enhance their service delivery in the health sector, will find this contract beneficial for growth and expansion.